Skip to main content
PBYI
NASDAQ Life Sciences

Puma Q3 Net Income Falls to $6.0M; Full-Year Profit Outlook Raised to $20-22M

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$9.77
Mkt Cap
$504.328M
52W Low
$4.575
52W High
$11.5
52W Position info
114% above low
Off High info
15% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PBYI has more than doubled off its 52-week low of $4.575.

Summary

Puma reported Q3 2026 total revenue of $55.1M versus $54.5M a year ago, with net product revenue of $54.1M up from $51.9M. GAAP net income fell to $6.0M, or $0.11 per diluted share, from $8.8M, or $0.17, a year earlier, as R&D spending rose to $18.3M from $15.9M on alisertib trial activity. The company raised its full-year 2026 net income outlook to $20-22M from $17-20M, but narrowed total revenue guidance to $224-227M from $224-231M and lifted its gross-to-net assumption to 27.5%-28% from 26.5%-27.5%. Royalty revenue took a $2.1M hit from a change in accounting estimate after generic NERLYNX share in China crossed a threshold, and management said some ex-U.S. partner sales slipped from Q3 into Q4. Cash and marketable securities stood at $108.5M with no debt. Updated ALISCA-Breast1 data is due at the San Antonio Breast Cancer Symposium in December 2026.

At the time of this announcement, PBYI was trading at $9.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $504.3M. The 52-week trading range was $4.58 to $11.50. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

PBYI - Latest Insights

PBYI
Aug 06, 2026, 4:41 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.12
Real-time Price: $9.54 info
Change: +$1.42 (+17%) info
Market Cap: $504.328M info
PBYI
Aug 06, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $8.12
Real-time Price: $9.54 info
Change: +$1.42 (+17%) info
Market Cap: $504.328M info
PBYI
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.12
Real-time Price: $9.54 info
Change: +$1.42 (+17%) info
Market Cap: $504.328M info
PBYI
Jun 16, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.17
Real-time Price: $9.54 info
Change: +$2.37 (+33%) info
Market Cap: $504.328M info
PBYI
May 07, 2026, 5:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $7.29
Real-time Price: $9.54 info
Change: +$2.25 (+31%) info
Market Cap: $504.328M info